NLRP3 and Sepsis: This section reviews the design, characterization, and therapeutic potential of different types of nanocarriers, including inorganic, protein‐based, dendrimer‐based, lipid‐based, and polymer‐based carriers, in the context of NLRP3 inflammasome inhibition against sepsis.